Atlas Trials

Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma

Clinical trial NCT06710093 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06710093
Sponsor
Royal Marsden NHS Foundation Trust
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Metastatic Melanoma
Start date
2025-02-01
Primary completion
2028-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.